GlassScriptPhysician profile
Kourtney S Howell
NPI 1497185458
$3,859.54
in general payments reported to CMS, 2019-2025
18 companies · $642 in 2025
The $642 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $227 · 2023: $2,030 · 2024: $960 · 2025: $642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,793 · Travel and Lodging: $839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,793.45 |
| Travel and Lodging | $838.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,577.99 | 2023-2024 | Axonics, Bulkamid |
| Janssen Biotech, INC. | $708.08 | 2022-2025 | Erleada, Akeega, Rybrevant |
| Sumitomo Pharma America, INC. | $420.53 | 2023-2025 | Gemtesa |
| Dendreon Pharmaceuticals LLC | $250.57 | 2022-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $214.33 | 2023-2025 | |
| Boston Scientific Corporation | $154.09 | 2024-2025 | Axonics, Spaceoar System, Bulkamid |
| Abbvie INC. | $124.91 | 2023-2025 | |
| Pfizer INC. | $79.54 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $72.67 | 2022-2023 | Keytruda, Welireg, Lynparza |
| Myriad Genetic Laboratories, INC. | $50.80 | 2022-2024 | Prolaris, Myrisk |
| Urovant Sciences INC | $44.59 | 2022 | |
| Urogen Pharma, INC. | $41.12 | 2024 | |
| Immunitybio, INC. | $32.93 | 2024 | |
| Astellas Pharma US INC | $30.65 | 2022-2023 | Myrbetriq |
| Olympus America INC. | $16.00 | 2025 | Itind System |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $14.10 | 2025 | |
| Accord Healthcare, INC. | $13.95 | 2025 | |
| Novartis Pharmaceuticals Corporation | $12.69 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kourtney Howell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.